Effects of Diene Valepotriates from Valeriana glechomifolia on Na⁺/K⁺-ATPase Activity in the Cortex and Hippocampus of Mice

 

 Buy Article Permissions and Reprints

Abstract

Diene valepotriates obtained from Valeriana glechomifolia present antidepressant-like activity, mediated by dopaminergic and noradrenergic neurotransmissions. Also, previous studies have shown inhibitory activity of diene valepotriates towards Na⁺/K⁺-ATPase from the rat brain in vitro. Nevertheless, in vivo studies regarding the action of diene valepotriates on this enzyme are still lacking. Considering that Na⁺/K⁺-ATPase cerebral activity is involved in depressive disorders, the aim of this study was to investigate the effects of acute (5 mg/kg, p. o.) and repeated (5 mg/kg, p. o., once a day for three days) diene valepotriate administration on Na⁺/K⁺-ATPase activity in the cortex and hippocampus of mice submitted or not submitted to the forced swimming test. In addition, the protein expression of Na⁺/K⁺-ATPase α1, α2, and α3 isoforms in the cortex of mice repeatedly treated with diene valepotriates (and submitted or not submitted to the forced swimming test) was investigated. Diene valepotriates significantly decreased mice immobility time in the forced swimming test when compared to the control group. Only the animals repeatedly treated with diene valepotriates presented increased Na⁺/K⁺-ATPase activity in the cerebral cortex, and the exposure to the forced swimming test counteracted the effects of the diene valepotriates. No alterations in the hippocampal Na⁺/K⁺-ATPase activity were observed. Repeated diene valepotriate administration increased the cortical content of the α2 isoform, but the α3 isoform protein expression was augmented only in mice repeatedly treated with diene valepotriates and forced to swim. Mice treated with the vehicle and submitted to the forced swimming test also presented an increase in the content of the α2 isoform, but no alterations in Na⁺/K⁺-ATPase activity. These results suggest that cortical Na⁺/K⁺-ATPase may represent a molecular target of the diene valepotriates in vivo and long-term regulatory mechanisms are involved in this effect. Also, the forced swimming test per se influences the protein expression of Na⁺/K⁺-ATPase isoforms and counteracts the effects of the diene valepotriates on cortical Na⁺/K⁺-ATPase.

• References

• 1 Backlund A, Moritz T. Phylogenetic implications of an expanded valepotriate distribution in the Valerianaceae. Biochem System Ecol 1998; 26: 309-335
  CrossrefPubMedGoogle Scholar
• 2 Hatesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. show anxiolitic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 2008; 15: 2-15
  CrossrefPubMedGoogle Scholar
• 3 Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine 2010; 17: 674-678
  Google Scholar
• 4 Subhan F, Karim N, Gilani AH, Sewell RDE. Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles. Phytother Res 2010; 24: 686-691
  PubMedGoogle Scholar
• 5 Sah SP, Mathela CS, Chopra K. Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: behavioural and biochemical evidence. J Ethnopharmacol 2011; 135: 197-200
  CrossrefPubMedGoogle Scholar
• 6 World Health Organization. WHO Monographs on selected medicinal Plants. Malta: WHO Graphics; 1999
  Google Scholar
• 7 Holzmann I, Filho VC, Mora TC, Cáceres A, Martínez JV, Cruz SM, Souza MM. Evaluation of behavioral and pharmacological effects of hydroalcoholic extract of Valeriana prionophylla Standl. from Guatemala. Evid Based Complement Alternat Med 2011; 2011: 1-9
  PubMedGoogle Scholar
• 8 Liu XG, Gao PY, Wang GS, Song SJ, Li LZ, Li X, Yao XS, Zhang ZX. In vivo antidepressant activity of sesquiterpenes from the roots of Valeriana fauriei Briq. Fitoterapia 2012; 83: 599-603
  CrossrefPubMedGoogle Scholar
• 9 Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, Vogt KE, Rudolph U, Mohler H. GABA_A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 2009; 56: 174-181
  PubMedGoogle Scholar
• 10 Marder M, Viola H, Wasowski C, Fernández S, Medina JH, Paladini AC. 6-Methylapigenin and hesperidin: new Valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 2003; 75: 537-545
  CrossrefPubMedGoogle Scholar
• 11 Andreatini R, Leite JR. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur J Pharmacol 1994; 1: 233-235
  PubMedGoogle Scholar
• 12 Andreatini R, Sartori VA, Seabra ML, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytoter Res 2002; 165: 650-654
  PubMedGoogle Scholar
• 13 Maurmann N, Reolon GK, Rech SB, Fett-Neto AG, Roesler R. A valepotriate fraction of Valeriana glechomifolia shows sedative and anxiolytic properties and impairs recognition but not aversive memory in mice. Evid Based Complement Alternat Med 2011; 2011: 1-7
  PubMedGoogle Scholar
• 14 Salles LA, Silva AL, Rech SB, Zanatta N, Von Poser GL. Constituents of Valeriana glechomifolia Meyer. Biochem Syst Ecol 2000; 28: 907-910
  CrossrefPubMedGoogle Scholar
• 15 Silva AL, Rech SB, von Poser GL. Quantitative determination of valepotriates from Valeriana native to south Brazil. Planta Med 2002; 68: 570-572
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Müller LG, Salles LA, Stein AC, Betti AH, Sakamoto S, Cassel E, Vargas RF, von Poser GL, Rates SMK. Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 101-109
  CrossrefPubMedGoogle Scholar
• 17 Bettero GM, Salles L, Rosário RMF, von Poser GL, Rates SMK, Noël F, Quintas LEM. In vitro effect of valepotriates isolated from Valeriana glechomifolia on rat P-type ATPases. Planta Med 2011; 77: 1702-1706
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 Kaplan JH. Biochemistry of Na⁺,K⁺-ATPase. Annu Rev Biochem 2002; 71: 511-535
  CrossrefPubMedGoogle Scholar
• 19 Dobretsov M, Stimers JR. Neuronal function and α3 isoform of the Na⁺/K⁺-ATPase. Front Biosci 2005; 10: 2373-2396
  CrossrefPubMedGoogle Scholar
• 20 Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosem H, Lichtstein D. Involvement of Na⁺,K⁺-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006; 60: 491-499
  CrossrefPubMedGoogle Scholar
• 21 Goldstein I, Lerer E, Laiba E, Mallet J, Mujaheed M, Laurent C, Rosen H, Ebstein RP, Lichtstein D. Association between sodium- and potassium-activated adenosine triphosphatase α isoforms and bipolar disorders. Biol Psychiatry 2009; 65: 985-991
  CrossrefPubMedGoogle Scholar
• 22 Gamaro GD, Streck EL, Matté C, Prediger ME, Wyse ATS, Dalmaz C. Reduction of hippocampal Na⁺,K⁺-ATPase activity in rats subjected to an experimental model of depression. Neurochem Res 2003; 28: 1339-1344
  CrossrefPubMedGoogle Scholar
• 23 Vasconcellos APS, Zugno AI, Santos AHDP, Nietto FB, Crema LM, Gonçalves M, Franzon R, Wyse ATS, Rocha ER, Dalmaz C. Na⁺,K⁺-ATPase activity is reduced in hippocampus of rats submitted to an experimental model of depression: effect of chronic lithium treatment and possible involvement in learning deficits. Neurobiol Learn Mem 2005; 84: 102-110
  CrossrefPubMedGoogle Scholar
• 24 Crema L, Schlabitz M, Tagliari B, Cunha A, Simão F, Krolow R, Pettenuzzo L, Salbego C, Vendite D, Wyse AT, Dalmaz C. Na⁺,K⁺-ATPase activity isreduced in amygdala of rats with chronic stress-induced anxiety-like behavior. Neurochem Res 2010; 35: 1787-1795
  CrossrefPubMedGoogle Scholar
• 25 Mcgrail KM, Phillips JM, Sweadner KJ. Immunofluorescent localization of three Na⁺,K⁺ ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na⁺,K⁺ ATPase. J Neurosci 1991; 11: 381-391
  PubMedGoogle Scholar
• 26 Moseley AE, Lieske SP, Wetzel RK, James PF, He S, Shelly DA, Paul RJ, Boivin GP, Witte DP, Ramirez JM, Sweadner KJ, Lingrel JB. The Na⁺,K⁺ ATPase α2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice. J Biol Chem 2003; 278: 5317-5324
  CrossrefPubMedGoogle Scholar
• 27 Gritz SM, Radcliffe RA. Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models. Hum Genomics 2013; 7: 8-14
  CrossrefPubMedGoogle Scholar
• 28 Heinzen EL, Arzimanoglou A, Brashear A, Clapcote SJ, Gurrieri F, Goldstein DB, Jóhannesson SH, Mikati MA, Neville B, Nicole S, Ozelius LJ, Poulsen H, Schyns T, Sweadner KJ, van den Maagdenberg A, Vilsen B. Distinct neurological disorders with ATP1A3 mutations. Lancet Neurol 2014; 13: 503-514
  CrossrefPubMedGoogle Scholar
• 29 De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G. Haploinsufficiency of ATP1A2 encoding the Na/K pump 2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33: 192-196
  CrossrefPubMedGoogle Scholar
• 30 De Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, Caton M, Linazasoro G, Borg M, Tijssen MA, Bressman SB, Dobyns WB, Brashear A, Ozelius LJ. Mutations in the Na⁺/K⁺-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004; 43: 169-175
  CrossrefPubMedGoogle Scholar
• 31 Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, Tiziano FD, Fontaine B, Walley NM, Heavin S, Panagiotakaki E, Fiori S, Abiusi E, Di Pietro L, Sweney MT, Newcomb TM, Viollet L, Huff C, Jorde LB, Reyna SP, Murphy KJ, Shianna KV, Gumbs CE, Little L, Silver K, Ptáček LJ, Haan J, Ferrari MD, Bye AM, Herkes GK, Whitelaw CM, Webb D, Lynch BJ, Uldall P, King MD, Scheffer IE, Neri G, Arzimanoglou A, van den Maagdenberg AM, Sisodiya SM, Mikati MA, Goldstein DB. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012; 44: 1030-1034
  CrossrefPubMedGoogle Scholar
• 32 Demos MK, van Karnebeek CD, Ross CJ, Adam S, Shen Y, Zhan SH, Shyr C, Horvath G, Suri M, Fryer A, Jones SJ, Friedman JM. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rar Dis 2014; 9: 15-23
  PubMedGoogle Scholar
• 33 Kirshenbaum GS, Saltzman K, Rose B, Petersen J, Vilsen B, Roder JC. Decreased neuronal Na⁺,K⁺-ATPase activity in ATP1A3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav 2011; 10: 542-550
  CrossrefPubMedGoogle Scholar
• 34 Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 2008; 60: 184-191
  CrossrefPubMedGoogle Scholar
• 35 Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006; 7: 137-141
  CrossrefPubMedGoogle Scholar
• 36 Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010; 35: 192-216
  CrossrefPubMedGoogle Scholar
• 37 Viana AF, Rates SMK, Naudin B, Janin F, Costentin J, do Rego JC. Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttifereae) extract of two established antidepressants on basal and stress induced increase in serum and brain corticosterone levels. J Psychopharmacol 2008; 22: 681-690
  CrossrefPubMedGoogle Scholar
• 38 Stein AC, Viana AF, Müller LG, Nunes JM, Stolz ED, Do Rego JC, Costentin J, von Poser GL, Rates SM. Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behav Brain Res 2012; 228: 66-73
  CrossrefPubMedGoogle Scholar
• 39 Erhardt E, Zibetti LC, Godinho JM, Bacchieri B, Barros HM. Behavioral changes induced by cocaine in mice are modified by a hyperlipidic diet or recombinant leptin. Braz J Med Biol Res 2006; 39: 1625-1635
  PubMedGoogle Scholar
• 40 Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 2005; 177: 245-255
  CrossrefPubMedGoogle Scholar
• 41 Porsolt RD, Anton G, Blavet N, Jafre M. Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47: 379-391
  CrossrefPubMedGoogle Scholar
• 42 Zanatta LM, Nascimento FC, Barros SV, Silva GR, Zugno AI, Netto CA, Wyse ATS. In vivo and in vitro effect of imipramine and fluoxetine on Na,K-ATPase activity in synaptic plasma membranes from the cerebral cortex of rats. Braz J Med Biol Res 2001; 34: 1265-1269
  CrossrefPubMedGoogle Scholar
• 43 Yallapragada PR, Butler J, Kumar BK, Rajanna B. In vitro effect of lead on Na⁺,K⁺-ATPase activity in different regions of adult rat brain. Drug Chem Toxicol 2003; 26: 117-124
  CrossrefPubMedGoogle Scholar
• 44 El-Mallakh RS, Wyatt RJ. The Na⁺K⁺ ATPase hypothesis for bipolar illness. Biol Psychiatry 1995; 37: 235-244
  CrossrefPubMedGoogle Scholar
• 45 Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52: 90-110
  CrossrefPubMedGoogle Scholar
• 46 Azuma KK, Hensley CB, Putnam DS, Mcdonough AA. Hypokalemia decreases Na⁺-K⁺-ATPase α2- but not α1-isoform abundance in heart, muscle, and brain. Am J Physiol 1991; 260: C958-C964
  PubMedGoogle Scholar
• 47 Ostadal P, Elmoselhi AB, Zdobnicka I, Lukas A, Elimban V, Dhalla NS. Role of oxidative stress in ischemia-reperfusion-induced changes in Na⁺,K⁺-ATPase isoform expression in rat heart. Antioxid Redox Signal 2004; 6: 914-923
  CrossrefPubMedGoogle Scholar
• 48 Goto A, Yamada K, Nagoshi H, Terano Y, Omata M. Stress-induced elevation of ouabain-like compound in rat plasma and adrenal. Hypertension 1995; 26: 1173-1176
  CrossrefPubMedGoogle Scholar
• 49 Therien AG, Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol 2000; 279: 541-566
  PubMedGoogle Scholar
• 50 Bersohn MM. Sodium pump inhibition in sarcolemma from ischemic hearts. J Mol Cell Cardiol 1995; 27: 1483-1489
  CrossrefPubMedGoogle Scholar
• 51 Golden WC, Brambrink AM, Traystman RJ, Martin LJ. Failure to sustain recovery of Na,K-ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Brain Res Mol Brain Res 2001; 88: 94-102
  CrossrefPubMedGoogle Scholar
• 52 Jamme I, Trouvé P, Maixent JM, Gerbi A, Charlemagne D, Nouvelot A. Regulation of Na+,K(+)-ATPase alpha subunit isoforms in mouse cortex during focal ischemia. Ann N Y Acad Sci 1997; 834: 658-660
  CrossrefPubMedGoogle Scholar
• 53 Jamme I, Petit E, Gerbi A, Maixent JM, MacKenzie ET, Nouvelot A. Changes in ouabain affinity of Na⁺, K⁺-ATPase during focal cerebral ischaemia in the mouse. Brain Res 1997; 774: 123-130
  CrossrefPubMedGoogle Scholar
• 54 Sun H, Zhang L, Ren C, Chen C, Fan S, Xia JJ, Lin H, Hu C. The expression of Na, K-ATPase in Litopenaeus vannamei under salinity stress. Mar Biol Res 2011; 7: 623-628
  CrossrefPubMedGoogle Scholar
• 55 Wang L, Wang WN, Liu Y, Cai DX, Li JZ, Wang AL. Two types of ATPases from the Pacific white shrimp, Litopenaeus vannamei in response to environmental stress. Mol Biol Rep 2012; 39: 6427-6438
  CrossrefPubMedGoogle Scholar
• 56 Mynett-Johnson L, Murphy V, Mccormack J, Shields DC, Claffey E, Manley P, Mckeon P. Evidence for an allelic association between bipolar disorder and a Na⁺, K⁺ adenosine triphosphatase α subunit gene (ATP1A3). Biol Psychiatry 1998; 44: 47-51
  CrossrefPubMedGoogle Scholar
• 57 Rose AM, Mellett BJ, Valdes jr. R, Kleinman JE, Herman MM, Li R, El-Mallakh RS. Alpha 2 isoform of the Na⁺,K⁺-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998; 44: 892-897
  CrossrefPubMedGoogle Scholar
• 58 Farman N, Bonvalet JP, Seckl JR. Aldosterone selectively increases Na⁺-K⁺-ATPase α3-subunit mRNA expression in rat hippocampus. Am J Physiol 1994; 266: C423-C428
  PubMedGoogle Scholar
• 59 Ewart HS, Klip A. Hormonal regulation of the Na⁺-K⁺-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 1995; 269: C295-C311
  PubMedGoogle Scholar
• 60 Müller LG, Salles LA, Sakamoto S, Stein AC, Cargnin ST, Cassel E, Vargas RF, Rates SMK, von Poser GL. Effect of storage time and conditions on the diene valepotriates content of the extract of Valeriana glechomifolia obtained by supercritical carbon dioxide. Phytochem Anal 2012; 23: 222-227
  CrossrefPubMedGoogle Scholar
• 61 Cassel E, Vargas RMF, Brun GW, Almeida DE, Cogoi L, Ferraro G, Filip R. Supercritical fluid extraction of alkaloids from Ilex paraguariensis St. Hill. J Food Eng 2010; 100: 656-661
  CrossrefPubMedGoogle Scholar
• 62 Brazil, Ministério Público. Lei nº 11.794, de 8 de outubro de 2008, Brasília – DF, Brazil.
  PubMedGoogle Scholar
• 63 Brazil, Ministério da Ciência, Tecnologia e Inovação, CONCEA. Diretriz brasileira para o cuidado e a utilização de animais para fins científicos e didáticos – DBCA. Portaria nº 465, de 23 de maio de 2013, Brasília – DF, Brazil.
  PubMedGoogle Scholar
• 64 Brazil, Ministério da Ciência, Tecnologia e Inovação, CONCEA. Diretrizes da prática de eutanásia do CONCEA. Portaria n. 596, de 25 de junho de 2013, Brasília – DF, Brazil.
  PubMedGoogle Scholar
• 65 Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336
  PubMedGoogle Scholar
• 66 Viana AF, Do Rego JC, von Poser GL, Ferraz A, Heckler AP, Constantin J, Rates SMK. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake. Neuropharmacology 2005; 49: 1042-1052
  CrossrefPubMedGoogle Scholar
• 67 Rezende DC, Pôças ES, Muzi-Filho H, Cunha VM, Caricati-Neto A, Jurkiewicz A, Noël F, Quintas LEM. Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice. J Physiol Biochem 2013; 69: 207-214
  CrossrefPubMedGoogle Scholar
• 68 Schaffazick N, Amaral LS, Fonseca TF, Tomaz MA, Gaban GA, Borges PA, Calil-Elias S, Noël F, Melo PA, Quintas LEM, Cunha VMN. Effect of heparin treatment on the expression and activity of different ion-motive P-type ATPase isoforms from mouse extensor digitorum longus muscle during degeneration and regeneration after Bothrops jararacussu venom injection. Toxicon 2010; 55: 52-60
  CrossrefPubMedGoogle Scholar
• 69 Quintas LEM, Noël F, Wibo M. Na⁺/K⁺-ATPase α isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment. Eur J Pharmacol 2007; 565: 151-157
  CrossrefPubMedGoogle Scholar